Salvage radiotherapy for biochemical recurrence after radical prostatectomy: A study of 62 patients

Urology

Volumn 62, Issue 3, 2003, Pages 503-507

  Peyromaure, Michaël ^a   Allouch, Mazen ^b   Eschwege, François ^b   Verpillat, Patrice ^b   Debré, Bernard ^b   Zerbib, Marc ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATECTOMY; RECURRENT DISEASE; SALVAGE THERAPY; SCORING SYSTEM;

EID: 0041733402     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00468-0     Document Type: Article

References (18)

1. Pound C.R., Partin A.W., Eiserberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597.
2. Soergel T.M., Koch M.O., Forster R.S., et al. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy. J Urol. 166:2001;2198-2201.
3. Partin A.W., Pearson J.D., Landis P.K., et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43:1994;649-659.
4. Cadeddu J.A., Partin A.W., DeWeese T.L., et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 159:1998;173-177.
5. Garg M.K., Tekyi-Mensah S., Bolton S., et al. Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. Urology. 51:1998;998-1002.
6. Vicini F.A., Ziaja E.L., Kestin L.L., et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology. 54:1999;111-117.
7. Nudell D.M., Grossfeld G.D., Weinberg V.K., et al. Radiotherapy after radical prostatectomy treatment outcomes and failure patterns . Urology. 54:1999;1049-1057.
8. Peschel R.E., Robnett T.J., Hesse D., et al. PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients. Int J Cancer. 90:2000;29-36.
9. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 163:2000;845-850.
10. Leventis A.K., Shariat S.F., Kattan M.W., et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 19:2001;1030-1039.
11. Vanuytzel L., Janssens G., Van Poppel H., et al. Radiotherapy for PSA recurrence after radical prostatectomy. Eur Urol. 39:2001;425-429.
12. Catton C., Gospodarowicz M., Warde P., et al. Adjuvant and salvage radiotherapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol. 59:2001;51-60.
13. Do L.V., Do T.M., Smith R., et al. Postoperative radiotherapy for carcinoma of the prostate impact on both local control and distant disease-free survival . Am J Clin Oncol. 25:2002;1-8.
14. Chawla A.K., Thakral H.K., Zietman A.L., et al. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma analysis of efficacy and prognosis factors . Urology. 59:2002;726-731.
15. Song D.Y., Thompson T.L., Ramakrishnan V., et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology. 60:2002;281-287.
16. Mayer R., Pummer K., Quehenberger F., et al. Postprostatectomy radiotherapy for high-risk prostate cancer. Urology. 59:2002;732-739.
17. Forman J.D., Meetze K., Pontes E., et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol. 158:1997;1436-1439.
18. Eulau S.M., Tate D.J., Stamey T.A., et al. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys. 41:1998;735-740.